FI933531A7 - PAF:n/H1:n imidatsopyridiiniantagonisteja - Google Patents

PAF:n/H1:n imidatsopyridiiniantagonisteja Download PDF

Info

Publication number
FI933531A7
FI933531A7 FI933531A FI933531A FI933531A7 FI 933531 A7 FI933531 A7 FI 933531A7 FI 933531 A FI933531 A FI 933531A FI 933531 A FI933531 A FI 933531A FI 933531 A7 FI933531 A7 FI 933531A7
Authority
FI
Finland
Prior art keywords
imidazopyridine
paf
antagonists
imidazopyridine antagonists
Prior art date
Application number
FI933531A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI933531L (fi
FI933531A0 (fi
Inventor
David Alker
Robert John Bass
Kelvin Cooper
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI933531L publication Critical patent/FI933531L/fi
Publication of FI933531A0 publication Critical patent/FI933531A0/fi
Publication of FI933531A7 publication Critical patent/FI933531A7/fi
Priority to FI973558A priority Critical patent/FI101225B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Prostheses (AREA)
  • Cosmetics (AREA)
  • Steroid Compounds (AREA)
FI933531A 1991-02-13 1992-01-24 PAF:n/H1:n imidatsopyridiiniantagonisteja FI933531A7 (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI973558A FI101225B (fi) 1991-02-13 1997-08-29 Menetelmä terapeuttisesti käyttökelpoisten 2-metyyli-imidatso£4,5-c|py rid-1-yylijohdannaisten valmistamiseksi

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919102997A GB9102997D0 (en) 1991-02-13 1991-02-13 Therapeutic agents
PCT/EP1992/000163 WO1992014734A1 (en) 1991-02-13 1992-01-24 Imidazopyridine paf/h1 antagonists

Publications (3)

Publication Number Publication Date
FI933531L FI933531L (fi) 1993-08-10
FI933531A0 FI933531A0 (fi) 1993-08-10
FI933531A7 true FI933531A7 (fi) 1993-08-10

Family

ID=10689943

Family Applications (1)

Application Number Title Priority Date Filing Date
FI933531A FI933531A7 (fi) 1991-02-13 1992-01-24 PAF:n/H1:n imidatsopyridiiniantagonisteja

Country Status (29)

Country Link
US (1) US5358953A (https=)
EP (1) EP0572425B1 (https=)
JP (1) JP2506541B2 (https=)
KR (1) KR970005302B1 (https=)
CN (1) CN1040326C (https=)
AT (1) ATE109482T1 (https=)
AU (1) AU650322B2 (https=)
BR (1) BR9205615A (https=)
CA (1) CA2099381C (https=)
CZ (1) CZ280504B6 (https=)
DE (1) DE69200304T2 (https=)
DK (1) DK0572425T3 (https=)
EG (1) EG20085A (https=)
ES (1) ES2059212T3 (https=)
FI (1) FI933531A7 (https=)
GB (1) GB9102997D0 (https=)
HU (2) HUT65947A (https=)
IE (1) IE65125B1 (https=)
IL (1) IL100887A (https=)
MX (1) MX9200589A (https=)
MY (1) MY108437A (https=)
NO (1) NO300592B1 (https=)
NZ (1) NZ241597A (https=)
PL (1) PL169304B1 (https=)
RU (1) RU2114845C1 (https=)
TW (1) TW227000B (https=)
WO (1) WO1992014734A1 (https=)
YU (1) YU48238B (https=)
ZA (1) ZA921005B (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2042421B1 (es) * 1992-05-22 1994-08-01 Uriach & Cia Sa J Procedimiento para la obtencion de la 8-cloro-11-*1-*(5-metil-3-piridil)metil*-4-piperidiliden*-6,11-dihidro-5h-benzo*5,6*ciclohepta*1,2-b*piridina.
WO1996005201A1 (en) * 1994-08-10 1996-02-22 British Biotech Pharmaceuticals Limited Imidazopyridine derivatives as dual histamine (h1) and platelet activating factor (paf) antagonists
ES2087038B1 (es) * 1994-11-07 1997-03-16 Uriach & Cia Sa J Nuevas piperidinas con actividad antagonista del paf.
US5567711A (en) * 1995-04-19 1996-10-22 Abbott Laboratories Indole-3-carbonyl and indole-3-sulfonyl derivatives as platelet activating factor antagonists
GB9508748D0 (en) * 1995-04-28 1995-06-14 British Biotech Pharm Benzimidazole derivatives
EP0842175A1 (en) * 1995-08-05 1998-05-20 British Biotech Pharmaceuticals Limited Imidazopyridine derivatives
SE9801526D0 (sv) * 1998-04-29 1998-04-29 Astra Ab New compounds
CN100553636C (zh) 2000-08-04 2009-10-28 Dmi生物科学公司 二酮基哌嗪和包含它们的组合物的使用方法
EP2517718B1 (en) 2003-05-15 2016-03-02 Ampio Pharmaceuticals, Inc. Treatment of T-cell mediated diseases
US7687515B2 (en) * 2006-01-17 2010-03-30 N.V. Organon 6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives
NZ587050A (en) 2008-01-30 2012-08-31 Nippon Zoki Pharmaceutical Co Compounds featuring a tricyclic group double bonded to a piperidine group, as an antihistamine
JP5856843B2 (ja) 2008-05-27 2016-02-10 アンピオ ファーマシューティカルズ，インコーポレイテッド ジケトピペラジンを用いた医薬組成物
JP5978296B2 (ja) * 2011-06-28 2016-08-24 フジアン・ミンドン・レジュヴネイション・ファーマスーティカル・カンパニー・リミテッド 抗アレルギ性ベンゾシクロヘプタチオフェン誘導体
MY172699A (en) 2011-10-10 2019-12-10 Ampio Pharmaceuticals Inc Implantable medical devices with increased immune tolerance, and methods for making and implanting
EA028343B1 (ru) 2011-10-10 2017-11-30 Ампио Фармасьютикалз, Инк. Лечение дегенеративного заболевания сустава
EP2771007B1 (en) * 2011-10-28 2018-04-04 Ampio Pharmaceuticals, Inc. Treatment of rhinitis
BR112015020469A2 (pt) 2013-03-15 2020-01-28 Ampio Pharmaceuticals Inc Usos de da-dkp, composição e método para fornecimento de células-tronco a umindivíduo
RU2736513C2 (ru) 2014-08-18 2020-11-17 Ампио Фармасьютикалз, Инк. Лечение патологических состояний суставов
EP3310375A4 (en) 2015-06-22 2019-02-20 Ampio Pharmaceuticals, Inc. USE OF LOW-MOLECULAR FRACTIONS OF HUMAN SERUMALBUMINE IN THE TREATMENT OF ILLNESSES
CN113880801A (zh) * 2020-07-03 2022-01-04 合肥医工医药股份有限公司 一类三环化合物、其制备方法及其医药用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL132137C (https=) * 1963-04-24
EP0404797B1 (en) * 1988-03-15 1995-02-01 G.D. Searle & Co. 1H/3H-[4-(N,N-CYCLOALKYL AND/OR BRANCHED-ALKYLCARBOXAMIDO) -BENZYL]IMIDAZO[4,5-c]PYRIDINES AS PAF ANTAGONISTS
MY106964A (en) * 1988-04-28 1995-08-30 Schering Corp Fused polycyclic compounds, compositions, methods of manufacture, and their use as paf antagonists, antihistamines and/or antiinflammatory agents.
US5250681A (en) * 1988-06-02 1993-10-05 Ajinomoto Co., Inc. Piperidine derivatives and hypotensives containing the same
US5114919A (en) * 1990-02-26 1992-05-19 Merck & Co., Inc. Adjuncts in cancer chemotherapy
JPH0678340B2 (ja) * 1990-05-09 1994-10-05 フアイザー・インコーポレイテツド 喘息、関節炎および関連疾患の治療におけるアザベンジミダゾール

Also Published As

Publication number Publication date
NO932889L (no) 1993-08-13
ES2059212T3 (es) 1994-11-01
ZA921005B (en) 1993-08-12
WO1992014734A1 (en) 1992-09-03
NZ241597A (en) 1993-04-28
AU650322B2 (en) 1994-06-16
IL100887A (en) 1996-01-19
AU1168392A (en) 1992-09-15
EG20085A (en) 1997-05-31
YU14392A (sh) 1994-11-15
GB9102997D0 (en) 1991-03-27
FI933531L (fi) 1993-08-10
PL169304B1 (pl) 1996-06-28
TW227000B (https=) 1994-07-21
MY108437A (en) 1996-09-30
JP2506541B2 (ja) 1996-06-12
NO932889D0 (no) 1993-08-13
DE69200304T2 (de) 1994-12-08
CN1064275A (zh) 1992-09-09
KR970005302B1 (ko) 1997-04-15
BR9205615A (pt) 1994-05-17
HU211202A9 (en) 1995-11-28
RU2114845C1 (ru) 1998-07-10
IL100887A0 (en) 1992-11-15
IE920449A1 (en) 1992-08-12
IE65125B1 (en) 1995-10-04
MX9200589A (es) 1992-10-01
HUT65947A (en) 1994-08-29
EP0572425B1 (en) 1994-08-03
EP0572425A1 (en) 1993-12-08
CA2099381A1 (en) 1992-08-14
FI933531A0 (fi) 1993-08-10
JPH06504992A (ja) 1994-06-09
CA2099381C (en) 1996-07-09
NO300592B1 (no) 1997-06-23
CN1040326C (zh) 1998-10-21
DK0572425T3 (da) 1994-09-12
US5358953A (en) 1994-10-25
YU48238B (sh) 1997-08-22
CZ280504B6 (cs) 1996-02-14
HU9302327D0 (en) 1993-10-28
DE69200304D1 (de) 1994-09-08
CS42592A3 (en) 1992-09-16
ATE109482T1 (de) 1994-08-15

Similar Documents

Publication Publication Date Title
FI933531A7 (fi) PAF:n/H1:n imidatsopyridiiniantagonisteja
DE69202186D1 (de) N-substituierte-4-Phenyl-Piperidin-Opioid Antagoniste.
FI935880A7 (fi) Immobiliserade lewis-syrakatalysatorer
FI935279L (fi) Tricykliska polyhydroxyltyrosinkinasininhibitorer
DK0546607T3 (da) Dispenser
NO922112L (no) Bicykliske rapamyciner
FI935134A7 (fi) Substituoidut 3-aminokinuklidiinit
FI925100A7 (fi) Substituoituja bifenyylipyridoneja
DE69219196D1 (de) Rheologiekontrollierende Zusatzmittel
NO924890L (no) Imidazopyridiner
FI924405A7 (fi) Lhrh-antagonister
FI757U1 (fi) Saekerhetsanordning hos en tryckkokares locklaos
DE69210561D1 (de) Dosierspender
DE69213616D1 (de) Zerstäuber
FI924300A7 (fi) Trisyklisiä heterosyklejä
FI925054A7 (fi) Imidatsopyridiini-PAF-antagonisteja
FI923342L (fi) Pleuromutilinkomplex
NO920266L (no) Pyridin-forbindelser
FI935280L (fi) Dihydroxiindanontyrosinkinasinhibitorer
DE69232141D1 (de) Sender-Empfänger
FI930108A7 (fi) Imidatsopyridiini-PAF-antagonisteja
FI925317A0 (fi) Makrocykliska laktamderivat
TR25953A (tr) SüBSTITüE EDILMIS 2-ARILPIROLLER
NZ241872A (en) Substituted oxaspirononane paf antagonists
DE69121379D1 (de) Zerstäuber

Legal Events

Date Code Title Description
FC Application refused